By Professor Sallie Pearson

Journal articles

Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA, 2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, 28, pp. 97 - 105, http://dx.doi.org/10.1002/pds.4683

Chalmers K; Badgery-Parker T; Pearson SA; Brett J; Scott I; Elshaug AG, 2019, 'Measuring 21 low-value health care procedures in Australian private health insurance claims data (2010 – 2014)', BMJ

Campbell G; Lintzeris N; Gisev N; Larance B; Pearson S; Degenhardt L, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, 210, pp. 6 - e1, http://dx.doi.org/10.5694/mja2.12047

Brett J; Zoega H; Buckley NA; Daniels BJ; Elshaug AG; Pearson SA, 2018, 'Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia', BMC Health Services Research, 18, pp. 1009, http://dx.doi.org/10.1186/s12913-018-3811-5

Morgan A; Joshy G; Schaffer A; Laba T-L; Litchfield M; Pearson S; Banks E, 2018, 'Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants', PLoS ONE, 13, pp. e0208824, http://dx.doi.org/10.1371/journal.pone.0208824

Gisev N; Pearson SA; Dobbins T; Currow DC; Blyth F; Larney S; Dunlop A; Mattick RP; Wilson A; Degenhardt L, 2018, 'Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2018-025840

Gisev N; Campbell G; Lalic S; Larney S; Peacock A; Nielsen S; Pearson SA; Degenhardt L, 2018, 'Current Opioid Access, Use, and Problems in Australasian Jurisdictions', Current Addiction Reports, 5, pp. 464 - 472, http://dx.doi.org/10.1007/s40429-018-0227-6

Henry D; Stehlik P; Camacho X; Pearson SA, 2018, 'Access to routinely collected data for population health research: experiences in Canada and Australia', Australian and New Zealand Journal of Public Health, 42, pp. 430 - 433, http://dx.doi.org/10.1111/1753-6405.12813

Lopez D; Daniels B; Sanfilippo F; Pearson S; Martini A; Preen DB, 2018, 'Needs and priority areas for building capacity for working with linked data in the Australian pharmacoepidemiology workforce', International Journal of Population Data Science, 3, http://dx.doi.org/10.23889/ijpds.v3i4.733

Cairns R; Schaffer A; Ryan N; Pearson S; Buckley NA, 2018, 'Rising pregabalin use and misuse in Australia: trends in utilisation and intentional poisonings', Addiction, 114, pp. 1026 - 1034, http://dx.doi.org/10.1111/add.14412

Bell JC; Bentley JP; Downie C; Cairns R; Buckley NA; Katelaris A; Pearson SA; Nassar N, 2018, 'Accidental pharmacological poisonings in young children: population-based study in three settings', Clinical Toxicology, 56, pp. 782 - 789, http://dx.doi.org/10.1080/15563650.2017.1422509

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)', Breast Cancer Research and Treatment, 171, pp. 151 - 159, http://dx.doi.org/10.1007/s10549-018-4804-0

Daniels B; Girosi F; Tervonen H; Kiely BE; Lord SJ; Houssami N; Pearson SA, 2018, 'Adherence to prescribing restrictions for her2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)', Plos One, 13, http://dx.doi.org/10.1371/journal.pone.0198152

Van de Velde S; Kunnamo I; Roshanov P; Kortteisto T; Aertgeerts B; Vandvik PO; Flottorp S; Delvaux N; Cloetens H; Spitaels D; Heselmans A; Codron T; Håvelsrud K; Rosenbaum S; Salonen S; Agarwal S; Ahmadian L; Bates D; Brandt L; Brignardello-Petersen R; Cauwenbergh C; Chen Y; Conway N; Durieux P; El-Kareh R; Fretheim A; Greenes R; Haynes RB; Holt T; Jenders RA; Kawamoto K; Kredo T; Lomotan E; Lugtenberg M; Marco-Ruiz L; McCowan C; McDermott L; Medlock S; Michaels M; Middleton B; Mitchell M; Moja L; Mugisha M; Osheroff JA; Coello PA; Pearson SA; Pelayo S; Richardson J; Ross P; Schreurs N; Semler M; Sittig D; Tamrat T; Tiik M; Turusheva A; van der Sijs H; Stichele RV; Vermandere M; Viall A; Venkateswaran M; Wright A; Young T, 2018, 'The GUIDES checklist: Development of a tool to improve the successful use of guideline-based computerised clinical decision support', Implementation Science, 13, http://dx.doi.org/10.1186/s13012-018-0772-3

Brett J; Maust DT; Bouck Z; Ignacio RV; Mecredy G; Kerr EA; Bhatia S; Elshaug AG; Pearson SA, 2018, 'Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016', Journal of the American Geriatrics Society, 66, pp. 1180 - 1185, http://dx.doi.org/10.1111/jgs.15292

Van Leeuwen MT; Luu S; Gurney H; Brown MR; Webber K; Pearson SA; Hunt L; Vajdic CM, 2018, 'Cardiovascular toxicity of targeted therapies for cancer: A protocol for an overview of systematic reviews', BMJ Open, 8, pp. e021064, http://dx.doi.org/10.1136/bmjopen-2017-021064

Blanch B; Degenhardt L; Buckley NA; Gisev N; Dobbins T; Karanges EA; Larance B; Larney S; Pearson SA, 2018, 'Prescription opioid access patterns and factors associated with increasing number of prescribers, pharmacies, and dispensings: An observational study using pharmaceutical claims', Pain Medicine United States, 19, pp. 1170 - 1183, http://dx.doi.org/10.1093/pm/pnx035

Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L, 2018, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Pharmacoepidemiology and Drug Safety, 27, pp. 550 - 555, http://dx.doi.org/10.1002/pds.4329

Karanges EA; Buckley NA; Brett J; Blanch B; Litchfield M; Degenhardt L; Pearson SA, 2018, 'Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics', Pharmacoepidemiology and Drug Safety, 27, pp. 504 - 512, http://dx.doi.org/10.1002/pds.4369

Reekie J; Roberts C; Preen D; Hocking JS; Donovan B; Ward J; Mak DB; Liu B; Guy R; Kaldor J; Pearson SA; Stewart L; Wand H, 2018, 'Chlamydia trachomatis and the risk of spontaneous preterm birth, babies who are born small for gestational age, and stillbirth: a population-based cohort study', Lancet Infectious Diseases, 18, pp. 452 - 460, http://dx.doi.org/10.1016/S1473-3099(18)30045-8

Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA, 2018, 'The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 27, pp. 439 - 446, http://dx.doi.org/10.1002/pds.4408

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001–2016)', Breast, 38, pp. 7 - 13, http://dx.doi.org/10.1016/j.breast.2017.11.007

Schaffer A; Buckley NA; Degenhardt L; Larance B; Cairns R; Dobbins T; Pearson SA, 2018, 'Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia', Canadian Medical Association Journal, 190, pp. E355 - E362, http://dx.doi.org/10.1503/cmaj.170666

Langton JM; Goldsbury D; Srasuebkul P; Ingham JM; O'Connell DL; Pearson SA, 2018, 'Insights from linking routinely collected data across Australian health jurisdictions: a case study of end-of-life health service use', Public Health Research and Practice, 28, pp. e2811806 - e2811806, http://dx.doi.org/10.17061/phrp2811806

Chalmers K; Badgery-Parker T; Pearson SA; Brett J; Scott IA; Elshaug AG, 2018, 'Developing indicators for measuring low-value care: Mapping Choosing Wisely recommendations to hospital data', BMC Research Notes, 11, http://dx.doi.org/10.1186/s13104-018-3270-4

Daniels B; Kiely BE; Houssami N; Lord SJ; Dobbins T; Lu CY; Ward RL; Pearson S-A, 2018, 'Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014)', BRITISH JOURNAL OF CANCER, 118, pp. 441 - 447, http://dx.doi.org/10.1038/bjc.2017.405

Sanjida S; Mulvogue K; Shaw J; Couper J; Kissane D; Pearson SA; Price MA; Janda M, 2018, 'What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital', Supportive Care in Cancer, 26, pp. 625 - 634, http://dx.doi.org/10.1007/s00520-017-3876-4

Reekie J; Donovan B; Guy R; Hocking JS; Kaldor JM; Mak DB; Pearson S; Preen D; Stewart L; Ward J; Liu B; Roberts C; Wand H, 2018, 'Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study', Clinical Infectious Diseases, 66, pp. 437 - 443, http://dx.doi.org/10.1093/cid/cix769

Badgery-Parker T; Pearson SA; Chalmers K; Brett J; Scott IA; Dunn S; Onley N; Elshaug AG, 2018, 'Low-value care in Australian public hospitals: Prevalence and trends over time', BMJ Quality and Safety, 28, pp. 205 - 214, http://dx.doi.org/10.1136/bmjqs-2018-008338

Harris CA; Daniels B; Ward RL; Pearson SA, 2017, 'Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012', Public Health Research and Practice, 27, http://dx.doi.org/10.17061/phrp2751744

Schaffer AL; Buckley NA; Pearson SA, 2017, 'Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy', Pharmacoepidemiology and Drug Safety, 26, pp. 1465 - 1473, http://dx.doi.org/10.1002/pds.4342

Brett J; Daniels B; Karanges EA; Buckley NA; Schneider C; Nassir A; McLachlan AJ; Pearson SA, 2017, 'Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study', British Journal of Clinical Pharmacology, 83, pp. 2581 - 2588, http://dx.doi.org/10.1111/bcp.13369

Gnjidic D; Du W; Pearson SA; Hilmer SN; Banks E, 2017, 'Ascertainment of self-reported prescription medication use compared with pharmaceutical claims data', Public Health Research and Practice, 27, http://dx.doi.org/10.17061/phrp27341702

Pearce A; Haas M; Viney R; Pearson SA; Haywood P; Brown C; Ward R, 2017, 'Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study', Plos One, 12, pp. e0184360, http://dx.doi.org/10.1371/journal.pone.0184360

Hálfdánarson Ó; Zoëga H; Aagaard L; Bernardo M; Brandt L; Fusté AC; Furu K; Garuoliené K; Hoffmann F; Huybrechts KF; Kalverdijk LJ; Kawakami K; Kieler H; Kinoshita T; Litchfield M; López SC; Machado-Alba JE; Machado-Duque ME; Mahesri M; Nishtala PS; Pearson SA; Reutfors J; Saastamoinen LK; Sato I; Schuiling-Veninga CCM; Shyu YC; Skurtveit S; Verdoux H; Wang LJ; Yahni CZ; Bachmann CJ; Zoega H; Halfdanarson OO, 2017, 'International trends in antipsychotic use: A study in 16 countries, 2005–2014', European Neuropsychopharmacology, 27, pp. 1064 - 1076, http://dx.doi.org/10.1016/j.euroneuro.2017.07.001

Brett J; Karanges EA; Daniels B; Buckley NA; Schneider C; Nassir A; Zoega H; McLachlan AJ; Pearson SA, 2017, 'Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure', Australian and New Zealand Journal of Psychiatry, 51, pp. 990 - 999, http://dx.doi.org/10.1177/0004867417721018

Chalmers K; Pearson SA; Elshaug AG, 2017, 'Quantifying low-value care: A patient-centric versus servicecentric lens', BMJ Quality and Safety, 26, pp. 855 - 858, http://dx.doi.org/10.1136/bmjqs-2017-006678

Roxburgh A; Hall WD; Dobbins T; Gisev N; Burns L; Pearson S; Degenhardt L, 2017, 'Trends in heroin and pharmaceutical opioid overdose deaths in Australia', Drug and Alcohol Dependence, 179, pp. 291 - 298, http://dx.doi.org/10.1016/j.drugalcdep.2017.07.018

Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA, 2017, 'Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data', Asia Pacific Journal of Clinical Oncology, 13, pp. e246 - e252, http://dx.doi.org/10.1111/ajco.12602

Ahmad T; Bouwman RA; Grigoras I; Aldecoa C; Hofer C; Hoeft A; Holt P; Buhre W; Pearse RM; Clavien PA; Demartines N; Grocott M; Haddow J; Holt P; Moreno R; Pritchard N; Rhodes A; Wilson M; Ahmed T; Halliwell R; Shulman M; Myles P; Schmid W; Hiesmayr M; Wouters P; De Hert S; Lobo S; Beattie S; Wijeysundera D; Fang X; Rasmussen L; Futier E; Biais M; Venara A; Slim K; Sander M; Koulenti D; Arvaniti K; Chan M; Kulkarni A; Chandra S; Tantri A; Geddoa E; Abbas M; Della Rocca G; Sivasakthi D; Mansor M; Luna P; Beavis V; Campbell D; Short T; Osinaike T; Matos R; Grigoras I; Kirov M; Protsenko D; Biccard BM; Chew M; Hübner M; Ditai J; Szakmany T; Fleisher L; Ferguson M; MacMahon M; Cherian R; Currow H; Kanathiban K; Gillespie D; Pathmanathan E; Phillips K; Reynolds J; Rowley J; Douglas J; Kerridge R; Garg S; Bennett M; Jain M; Alcock D; Terblanche N; Cotter R; Leslie K; Stewart M; Zingerle N; Clyde A; Hambidge O; Rehak A; Cotterell S; Huynh WBQ; McCulloch T; Ben-Menachem E; Egan T; Cope J; Fellinger P; Markus P; Haselberger S; Holaubek C; Lichtenegger P; Scherz F; Hoffer F, 2017, 'Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: A 7-day cohort study of elective surgery', British Journal of Anaesthesia, 119, pp. 258 - 266, http://dx.doi.org/10.1093/bja/aex185

Todd A; Husband A; Andrew I; Pearson SA; Lindsey L; Holmes H, 2017, 'Inappropriate prescribing of preventative medication in patients with life-limiting illness: A systematic review', BMJ Supportive and Palliative Care, 7, pp. 113 - 121, http://dx.doi.org/10.1136/bmjspcare-2015-000941

Brett J; Elshaug AG; Bhatia RS; Chalmers K; Badgery-Parker T; Pearson SA, 2017, 'A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: An Australian case study', Implementation Science, 12, pp. 58, http://dx.doi.org/10.1186/s13012-017-0585-9

Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L, 2017, 'Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment', Pharmacoepidemiology and Drug Safety, 26, pp. 587 - 591, http://dx.doi.org/10.1002/pds.4168

Du W; Pearson SA; Buckley NA; Day C; Banks E, 2017, 'Diagnosis-based and external cause-based criteria to identify adverse drug reactions in hospital ICD-coded data: Application to an Australian population-based study', Public Health Research and Practice, 27, http://dx.doi.org/10.17061/phrp2721716

Blanch B; Gladstone E; Smolina K; Buckley NA; Karanges EA; Morgan SG; Pearson SA, 2017, 'Benchmarking prescription drug access patterns in pharmaceutical claims: a method for identifying high and potentially harmful opioid use in Australia and Canada?', Journal of Pharmaceutical Health Services Research, 8, pp. 23 - 30, http://dx.doi.org/10.1111/jphs.12165

Morley KC; Logge W; Pearson SA; Baillie A; Haber PS, 2017, 'Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence', Journal of Substance Abuse Treatment, 74, pp. 23 - 25, http://dx.doi.org/10.1016/j.jsat.2016.12.004

Pace J; Pearson SA; Lipworth W, 2017, 'Legitimacy of medicines funding in the era of accelerated access', International Journal of Technology Assessment in Health Care, 33, pp. 700 - 707, http://dx.doi.org/10.1017/S0266462317000794

Reekie J; Donovan B; Guy R; Hocking JS; Kaldor JM; Mak DB; Pearson S; Preen D; Wand H; Ward J; Liu B, 2017, 'Trends in chlamydia and gonorrhoea testing and positivity in Western Australian Aboriginal and non-Aboriginal women 2001-2013: A population-based cohort study', Sexual Health, 14, pp. 574 - 580, http://dx.doi.org/10.1071/SH16207

Daniels B; Lord SJ; Kiely BE; Houssami N; Haywood P; Lu CY; Ward RL; Pearson SA, 2017, 'Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort', BMJ Open, 7, http://dx.doi.org/10.1136/bmjopen-2016-014439

Reeve R; Srasuebkul P; Langton J; Haas M; Viney R; Pearson S, 2017, 'Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history', BMC Palliative Care, 17, pp. 1, http://dx.doi.org/10.1186/s12904-017-0213-0

Back to profile page